Posted by Michael Wonder on 18 Mar 2024
Zymfentra (infliximab-dyyb), the first and only FDA approved subcutaneous infliximab, now commercially available in the U.S.
17 March 2024 - Zymfentra is commercially available across the US on 15 March 2024.
Celltrion USA announced today the availability of a Zymfentra (infliximab-dyyb), a subcutaneous formulation of infliximab.
